Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Soliman

Showing results (421-430 of 424) with videos related to

Pageof 43
Sort By:
You have reached the last page of results.This site can display upto 424 results.
Nature|September 5, 2025
Author Correction: PPP2R1A mutations portend improved survival after cancer immunotherapyYibo Dai, Anne Knisely, Mitsutake Yano, et al.
Nature|July 3, 2025
PPP2R1A mutations portend improved survival after cancer immunotherapyYibo Dai, Anne Knisely, Mitsutake Yano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2025
Surgical and blood-based minimal residual disease in patients with ovarian cancer after frontline therapy: Clinical outcomes and translational opportunitiesAnne Knisely, Yibo Dai, Graham L Barlow, et al.
Gynecologic Oncology|August 21, 2019
Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancerKoji Matsuo, James C Cripe, Katherine C Kurnit, et al.
Pageof 43

Showing results (421-430 of 424) with videos related to

Sort By:
Pageof 43
You have reached the last page of results.This site can display upto 424 results.
Nature|September 5, 2025
Author Correction: PPP2R1A mutations portend improved survival after cancer immunotherapyYibo Dai, Anne Knisely, Mitsutake Yano, et al.
Nature|July 3, 2025
PPP2R1A mutations portend improved survival after cancer immunotherapyYibo Dai, Anne Knisely, Mitsutake Yano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2025
Surgical and blood-based minimal residual disease in patients with ovarian cancer after frontline therapy: Clinical outcomes and translational opportunitiesAnne Knisely, Yibo Dai, Graham L Barlow, et al.
Gynecologic Oncology|August 21, 2019
Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancerKoji Matsuo, James C Cripe, Katherine C Kurnit, et al.
Pageof 43